Home Blog Page 1544

AMBITIONS ENTERPRISE MANAGEMENT CO. L.L.C Reports Unaudited Financial Results for the Six Months Ended June 30, 2025

By
Advertorial Desk
-

DUBAI, UAE, Dec. 8, 2025 /PRNewswire/ — AMBITIONS ENTERPRISE MANAGEMENT CO. L.L.C, (the “Company”) (Nasdaq: AHMA), a United Arabic Emirates-based MICE (meetings, incentives, conferences, and exhibitions) and tourism services provider, today announced its unaudited financial results for the six months ended June 30, 2025.

Financial Highlights for the Six Months Ended June 30, 2025

  • Revenue increased by 14% to US$9.7 million for the six months ended June 30, 2025, from US$8.5 million for the six months ended June 30, 2024.
  • MICE management solution services revenue increased by 38% to US$8.7 million for the six months ended June 30, 2025, from US$6.3 million for the six months ended June 30, 2024.
  • Operating income increased by 164% to US$333,003 for the six months ended June 30, 2025, from US$126,257 for the six months ended June 30, 2024.
  • Net income increased by 191% to US$328,897 for the six months ended June 30, 2025, from US$113,071 for the six months ended June 30, 2024.

Mr. Zhengang Tang, Chairman of the Board of Directors and Chief Executive Officer of the Company, commented, “For the six months ended June 30, 2025, the Company delivered 14% year-over-year revenue growth and a 191% year-over-year increase in net income. These achievements reflect the strong momentum in the United Arabic Emirates (“UAE”) MICE sector as well as our team’s execution prowess. Looking ahead, we intend to continue to sharpen operational efficiency, scale our core strength, invest in innovation, and strive to pursue high-quality, sustainable growth.”

Ms. Li Zhang, the Chief Financial Officer of the Company, added, “We drove year-over-year increases in revenue and profitability for the six months ended June 30, 2025. Notably, operating income and net income rose 164% and 191% year over year, respectively, demonstrating our ability of driving cost efficiency and operational discipline.”

Unaudited Financial Results for the Six Months Ended June 30, 2025

Revenue increased by 14% to approximately US$9.7 million for the six months ended June 30, 2025, from US$8.5 million for the six months ended June 30, 2024, primarily due to the increased demand for MICE services from the corporate customers driven by the recovery in MICE travel from the COVID-19 pandemic and the UAE government’s support for the tourism industry.

Cost of revenues increased by 17% to approximately US$7.9 million for the six months ended June 30, 2025, from US$6.7 million for the six months ended June 30, 2024, primarily due to the increased number of tourist guide employed to meet the increased demand for MICE management services.

Gross profit increased by 3% to approximately US$1.9 million for the six months ended June 30, 2025, from US$1.8 million for the six months ended June 30, 2024.

Selling and marketing expenses increased by 12% to approximately US$0.75 million for the six months ended June 30, 2025, from US$0.67 million for the six months ended June 30, 2024, primarily due to the increase of the compensation to sales personnel, including salaries, performance-based bonus, and other benefits, aligned with the growth in revenue.

General and administrative expenses decreased by 23% to approximately US$0.79 million for the six months ended June 30, 2025, from US$1.03 million for the six months ended June 30, 2024, primarily due to the Company’s ongoing efforts to streamline office procedures and enhance employee efficiency, which led to a reduction in staff costs.

Operating expenses decreased by 9% to US$1.5 million for the six months ended June 30, 2025, from US$1.7 million for the six months ended June 30, 2024.

Operating income increased by 164% to US$333,003 for the six months ended June 30, 2025, from US$126,257 for the six months ended June 30, 2024.

Net income increased by 191% to approximately US$328,897 for the six months ended June 30, 2025, from US$113,071 for the six months ended June 30, 2024.

Basic and diluted net income per share attributable to holders of ordinary shares of the Company were US$0.01 for the six months ended June 30, 2025.

Cash Position and Cash Flow

As of June 30, 2025, the Company had cash and cash equivalents and restricted cash of US$1.3 million, compared with US$1.3 million as of December 31, 2024.

For the six months ended June 30, 2025, net cash provided by operating activities was US$312,305.

About AMBITIONS ENTERPRISE MANAGEMENT CO. L.L.C

As a UAE-based MICE and tourism services provider, the Company serves a global client base by delivering expert event management and seamless, one-stop travel solutions. Guided by an experienced management team and supported by partnerships across the tourism and hospitality industries in the Middle East, Europe, Africa, and the Americas, the Company executes large-scale events for clients from diverse sectors. Additionally, the Company manages bespoke travel experiences, providing a one-stop guided tour service that streamlines travel across the UAE and its neighboring countries, as well as to other global destinations.

For more information, please visit https://ir.ambitions.ae.

Forward-Looking Statements

This press release contains statements that may constitute “forward-looking” statements which are made pursuant to the “safe harbor” provisions of the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements involve known and unknown risks and uncertainties and are based on the Company’s current expectations and projections about future events that the Company believes may affect its financial condition, results of operations, business strategy, and financial needs. Investors can find many (but not all) of these statements by the use of words such as “approximates,” “believes,” “hopes,” “expects,” “anticipates,” “estimates,” “projects,” “intends,” “plans,” “will,” “would,” “should,” “could,” “may,” or other similar expressions in this press release. The Company undertakes no obligation to update or revise publicly any forward-looking statements to reflect subsequent occurring events or circumstances, or changes in its expectations, except as may be required by law. Although the Company believes that the expectations expressed in these forward-looking statements are reasonable, it cannot assure you that such expectations will turn out to be correct, and the Company cautions investors that actual results may differ materially from the anticipated results and encourages investors to review other factors that may affect its future results in the Company’s registration statements and other filings with the U.S. Securities and Exchange Commission.

For investor and media inquiries, please contact:

AMBITIONS ENTERPRISE MANAGEMENT CO. L.L.C
Investor Relations
Email: Ambitions@thepiacentegroup.com

Piacente Financial Communications
Brandi Piacente
Tel: +1-212-481-2050
Email: Ambitions@thepiacentegroup.com

Jenny Cai
Tel: +86-10-6508-0677
Email: Ambitions@thepiacentegroup.com

 

 

AMBITIONS ENTERPRISE MANAGEMENT CO., L.L.C

CONDENSED CONSOLIDATED BALANCE SHEETS

(Amounts expressed in US dollars (“$”) except for numbers of shares and par value)

As of
June 30,
2025

As of
December 31,
2024

$

$

(Unaudited)

ASSETS

Current assets:

Cash and cash equivalents

1,035,626

986,768

Restricted cash

298,434

298,434

Accounts receivable, net

4,747,072

4,907,563

Prepayments and other current assets

2,275,559

1,893,288

Deferred offering costs

818,827

619,238

Amounts due from related parties

843,826

1,034,432

Total current assets

10,019,344

9,739,723

Non-current assets:

Equipment, net

168,600

138,263

Deferred tax assets

20,436

13,963

Right-of-use assets

77,790

98,852

Total non-current assets

266,826

251,078

Total assets

10,286,170

9,990,801

LIABILITIES AND SHAREHOLDERS’ EQUITY

Current liabilities:

Accounts payable

2,515,445

2,875,953

Amounts due to related party

34,477

39,566

Advance from customers

610,192

303,673

Operating lease liabilities, current

61,480

84,826

Income tax payable

140,567

109,454

Accrued expenses and other current liabilities

220,581

202,798

Total current liabilities

3,582,742

3,616,270

Total liabilities

3,582,742

3,616,270

 

 

AMBITIONS ENTERPRISE MANAGEMENT CO., L.L.C

CONDENSED CONSOLIDATED BALANCE SHEETS (CONTINUED)

(Amounts expressed in US dollars (“$”) except for numbers of shares and par value)

As of
June 30,
2025

As of
December 31,
2024

$

$

(Unaudited)

Shareholders’ equity:

Ordinary share, $0.0000001 par value; 399,966,500,000 Class A
    ordinary shares authorized; 9,240,000 Class A ordinary shares
    issued and outstanding as of June 30, 2025 and December 31, 2024

1

1

Ordinary share, $0.0000001 par value; 100,033,500,000 Class B
    ordinary shares authorized; 18,760,000 Class B ordinary shares
    issued and outstanding as of June 30, 2025 and December 31, 2024

2

2

Subscription receivable

(3)

(3)

Additional paid-in capital

81,688

81,688

Retained earnings

6,621,740

6,292,843

Total shareholders’ equity

6,703,428

6,374,531

Total liabilities and shareholders’ equity

10,286,170

9,990,801

 

 

AMBITIONS ENTERPRISE MANAGEMENT CO., L.L.C

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(Amounts expressed in US dollars (“$”) except for numbers of shares and par value)

For the Six Months
Ended June 30,

2025

2024

$

$

(Unaudited)

(Unaudited)

Revenue

9,739,933

8,512,330

Cost of revenue

(7,867,265)

(6,696,388)

Gross profit

1,872,668

1,815,942

Operating expenses:

Selling and marketing

(745,560)

(664,635)

General and administrative

(794,105)

(1,025,050)

Total operating expenses

(1,539,665)

(1,689,685)

Operating income

333,003

126,257

Interest income /(expenses), net

15,620

(3,908)

Other income, net

2,674

1,848

Income before income taxes

351,297

124,197

Income tax expenses

(22,400)

(11,126)

Net income

328,897

113,071

Net income per share attributable to ordinary shareholders
    of the Company

Basic and diluted

0.01

—

Weighted average shares used in calculating net earnings per share

Class A and Class B ordinary shares – Basic and diluted*

____________

28,000,000

28,000,000

 

*    Giving retroactive effect to the 9,240,000 class A ordinary shares and 18,760,000 class B ordinary shares issued and outstanding
following the share subdivision and share surrender on February 18, 2025, starting from the earliest period presented.

 

 

AMBITIONS ENTERPRISE MANAGEMENT CO., L.L.C

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(Amounts expressed in US dollars (“$”))

For the Six Months
Ended June 30,

2025

2024

$

$

(Unaudited)

(Unaudited)

Cash flows from operating activities:

Net income

328,897

113,071

Adjustments to reconcile net income to net cash used in operating activities:

Depreciation of equipment

32,014

20,556

Amortization of right-of-use assets

76,438

79,598

Allowance for credit loss

69,640

226,956

Changes in operating assets and liabilities:

Accounts receivable, net

88,309

102,953

Amount due from related parties

190,606

—

Prepayment and other current assets

(379,728)

(95,748)

Accounts payable

(360,509)

71,700

Operating lease liabilities

(78,722)

(79,659)

Advance from customers

306,519

(19,746)

Amounts due to related party

(5,089)

75,383

Income tax payables

32,620

—

Deferred tax

(6,473)

(20,431)

Accrued expenses and other current liabilities

17,783

(88,844)

Net cash provided by operating activities

312,305

385,789

Cash flows from investing activity:

Purchase of equipment

(63,858)

(2,689)

Net cash used in investing activity

(63,858)

(2,689)

Cash flows from financing activity:

Deferred offering costs

(199,589)

—

Net cash used in financing activities

(199,589)

—

Net increase in cash and cash equivalents and restricted cash

48,858

383,100

Cash and cash equivalents and restricted cash, beginning of period

1,285,202

778,952

Cash and cash equivalents and restricted cash, end of period

1,334,060

1,162,052

 

ALR TECHNOLOGIES TO RELAUNCH THE GLUCURVE PET CGM IN JANUARY 2026

By
Advertorial Desk
-

SINGAPORE, Dec. 8, 2025 /PRNewswire/ — ALR Technologies SG Ltd (“ALRT” or the “Company“) (OTC: ALRTF), the diabetes management company, announces the successful completion of internal manufacturing testing on the GluCurve Pet CGM (“GluCurve“) showing accuracy results comparative to the leading veterinary Blood Glucose Meter (“BGM“) and scheduling of its relaunch into the Canadian market for January 2026.

GluCurve is the first and only diabetic monitoring system built specifically for veterinary use on cats and dogs. A pet-friendly Continuous Glucose Monitor (“CGM”) sensor is painlessly attached to the pet and provides blood sugar levels every 3 minutes for up to 14 days. Pet owners can view the blood sugar readings on the GluCurve Pet CGM app. In addition, the blood sugar readings are uploaded to the ALRT Veterinary Web Portal, where they are displayed for the veterinarian to easily manage patients and adjust insulin dosing, either remotely or in person.

Joe Stern, Head of Animal Health at ALRT, states, “Based on the most commonly accepted diabetes prevalence rate studies and pet population surveys, we estimate the potential market size for the GluCurve to be between 150,000-300,000 units per year in Canada, 2,000,000-3,000,000 units per year in the United States, and a further 2,000,000-3,000,000 units per year in Europe. You cannot prick the finger of a cat or dog to check blood sugar as you would with a human, and even when you can draw blood from their ear, paw, or vein, a spot check of this nature does not provide the data needed to properly dose insulin or see trends as a CGM would. We believe this is why we have received so much interest and demand for the GluCurve Pet CGM from veterinarians, pet owners, and animal health companies, because there is a desperate need for a holistic product like ours to manage diabetic pets.

Mr. Stern continued, “We are thrilled to be partnered with CGM Medical Technology Shenzhen Ltd. on the manufacturing of CGM units for GluCurve and the development of a CGM for the human market. We have been working side by side with them to build out their manufacturing capabilities at the Foxconn facility in Shenzhen. After two years of hard work, we are approaching the launch of the new and improved GluCurve Pet CGM.”

ALRT has completed successful internal testing of the GluCurve Pet CGM showing results comparative to the most widely used BGM for cats and dogs, considered the gold standard by veterinarians. An independent non-inferiority study is scheduled for mid-December to further demonstrate its efficacy against the leading veterinary Blood Glucose Meter when compared to a chemistry analyzer.

At relaunch, veterinary clinics in Canada will be able to order directly from the official Canadian website (www.GluCurve.ca) while the Company works with purchasing groups and corporations for additional buying options. The relaunch of the GluCurve Pet CGM in the United States is planned for early Q2 2026 through an ongoing strategic relationship with a leading veterinary distributor, followed by a global launch throughout Europe, Australia, Asia, South America, and the rest of the world.

The Company will announce when GluCurve is for sale in Canada and any additional updates on sales, partnerships, and other material updates as they occur.

About ALR Technologies SG Ltd.

ALRT is a data management company that developed the ALRT Diabetes Solution, a comprehensive approach to diabetes care that includes an FDA-cleared and HIPAA compliant diabetes management system that collects data directly from blood glucose meters and continuous glucose monitoring devices, and Predictive A1C algorithm to track treatment success between lab reports and an FDA-cleared Insulin Dosing Adjustment program. The overall goal is to optimize diabetes drug therapies to drive improved patient outcomes.

In addition, the animal health division of ALRT has developed the GluCurve Pet CGM; a solution to assist veterinarians better determine the efficacy of insulin treatments and to help to identify the appropriate dose and frequency of administration for companion animals, thereby delivering the same optimization of diabetic drug therapies to pets as to humans.

More information about ALRT and the GluCurve Pet CGM can be found at www.alrt.com and www.GluCurve.com in the USA or www.GluCurve.ca in Canada

Investor Contact

Investor Relations: ir@alrt.com
Animal Health Inquiries: animalhealth@alrt.com
Media: Media@alrt.com
US: +1 804 368 3770
Singapore: +65 3129 2924

CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING INFORMATION:

This news release includes certain “forward-looking statements” as defined under applicable securities legislation. All information and statements contained herein that are not clearly historical in nature constitute forward-looking statements and information, and the words “anticipate”, “estimate”, “believe”, “continue”, “could”, “expect”, “intend”, “plan”, “postulates”, “predict”, “will”, “may” or similar expressions suggesting future conditions or events, or the negative of these terms, are generally intended to identify forward-looking information. Forward-looking statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable, are subject to known and unknown risks, uncertainties, and other factors which may cause the actual results and future events to differ materially from those expressed or implied by such forward-looking statements. Such risks include all risks and uncertainties expressed in the cautionary statements and risk factors in the annual report on Form 10-K and other filings of ALRT with the SEC. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Forward-looking statements include representations to the effect that the Company will launch GluCurve in January 2026, will have sales of GluCurve CGM and will have updates on sales, partnerships, and other material updates related to the distribution of GluCurve. The forward-looking statements included in this news release are made as of the date hereof. ALRT disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

PCBAIR Unveils 8-Layer Glass Core PCB Manufacturing for Next-Gen AI & HPC

By
Advertorial Desk
-

SHENZHEN, China, Dec. 8, 2025 /PRNewswire/ — PCBAIR announced the launch of its advanced 8-layer Glass Core PCB manufacturing capabilities, combining proprietary Through Glass Via (TGV) technology with multi-layer redistribution layers (RDL). The new glass substrates achieve superior signal integrity and thermal stability, addressing the critical interconnect density limitations faced by traditional organic substrates in the era of artificial intelligence and high-performance computing (HPC).

PCBAIR Glass Core PCB
PCBAIR Glass Core PCB

Designed for AI accelerators, high-speed data center servers, and optical transceivers, PCBAIR’s 8-layer Glass Core PCBs support finer line widths and spacing, with pilot production and customer sampling commencing immediately.

PCBAIR developed this high-density interconnect solution through specific innovations in glass processing, metallization, and stacking. Each technical improvement contributes to the reduction of signal loss and the enhancement of mechanical reliability:

  1. Precision TGV Technology – Achieving Through Glass Via (TGV) diameters of less than 20 μm and a pitch of under 100 μm. This significantly increases I/O density compared to standard organic substrates, allowing for more efficient vertical signal transmission between chiplets.
  2. Optimized 8-Layer Stack-up – Utilizing a symmetric build-up structure (typically 3-2-3 or 4-Core-4) to manage internal stress. This approach ensures exceptional flatness and reduces warpage issues often seen in large-body organic packages during reflow, which is critical for the assembly of large AI chipsets.
  3. Superior Electrical Performance – The glass core material offers a lower dielectric loss (Df < 0.002) compared to traditional epoxy-based materials. This reduction in insertion loss improves signal transmission efficiency by approximately 15%–20% for high-frequency applications, essential for next-generation 112G and 224G SerDes links.
  4. Thermal Management – The thermal expansion coefficient (CTE) of the glass core is closely matched to silicon dies. This minimizes stress on solder joints during thermal cycling, enhancing the long-term reliability of the packaged device.

Altogether, these improvements enable chip designers to bypass current packaging bottlenecks, allowing for higher performance scaling without the exponential cost increase associated with traditional silicon interposers.

“We are proud to introduce our 8-layer Glass Core PCB capabilities, marking a practical step forward in advanced packaging,” said Victor Zhang, a technology expert and the chief technology officer of PCBAIR. Zhang, whose technical insights have been recognized by major media outlets such as Forbes, added, “By moving from organic to glass cores, we are providing a stable foundation for the industry’s most demanding compute workloads, maintaining the precision and reliability our partners expect.”

PCBAIR’s Glass Core PCBs are also fully compatible with existing substrate assembly lines, ensuring a smoother transition for customers looking to adopt glass-based technology. The company offers a turnkey solution, handling the delicate manufacturing and assembly processes required for glass substrates to mitigate supply chain risks for its global clients.

About PCBAIR

Established in 2014, PCBAIR is a leading PCB manufacturer and assembly service provider dedicated to high-reliability electronics. With over a decade of expertise, the company provides a seamless one-stop solution ranging from rapid prototyping to high-volume manufacturing. PCBAIR’s services include PCB fabrication, component sourcing, and turnkey assembly. The company is certified to IATF 16949, ISO 13485, and ISO 9001, and adheres to IPC-A-610 and J-STD-001 standards. The company also ensures full environmental and safety compliance via UL, RoHS, and REACH certifications. For more information, visit www.pcbair.com.

For media inquiries, please contact: 
Cyndi
Marketing Manager
Email: Inquiry@pcbair.com
Website: https://www.pcbair.com

Zymedi Announces “rapaprutug” as the International Nonproprietary Name (INN) for ZMA001

By
Advertorial Desk
-

INCHEON, South Korea, Dec. 8, 2025 /PRNewswire/ — Zymedi (CEO Sunghoon Kim) announced that the World Health Organization (WHO) has assigned rapaprutug as the International Nonproprietary Name (INN) for the company’s first-in-class antibody therapy ZMA001, being developed as a treatment for pulmonary arterial hypertension (PAH).

The assignment of the name rapaprutug (development code: ZMA001) marks a key global milestone and establishes a unified scientific identity for Zymedi’s lead candidate as it advances through development. The antibody is currently being evaluated in an ongoing Phase 1 clinical trial at the National Institutes of Health (NIH) Clinical Center in the United States.

“We are very pleased that the WHO has designated the nonproprietary name rapaprutug for our lead PAH program,” said Sunghoon Kim, CEO and Founder of Zymedi and professor at Yonsei University. “This milestone underscores our team’s long-term efforts to discover and develop innovative biologic therapies that address the root causes of macrophage-driven inflammatory and fibrotic diseases such as pulmonary arterial hypertension and asthma. We remain committed to bringing meaningful treatments to patients worldwide.”

The WHO INN system assigns unique, globally recognized names for pharmaceutical substances to ensure clear international communication among scientists, regulators, and clinicians. The publication of rapaprutug in INN Recommended List 94 officially establishes the compound’s global nonproprietary identity.

About rapaprutug (ZMA001)

Rapaprutug (ZMA001) is a first-in-class human monoclonal antibody that exerts its therapeutic efficacy by inhibiting the infiltration of inflammation-inducing macrophages into the damaged tissues. In 2023, Zymedi entered into a Collaborative Research and Development Agreement (CRADA) with the U.S. National Institutes of Health (NIH) to advance the development of ZMA001, primarily to treat PAH. As part of this collaboration, the NIH Clinical Center initiated a Phase 1 clinical trial in healthy volunteers in January 2024. In July of the same year, the U.S. Food and Drug Administration (FDA) granted ZMA001 Orphan Drug Designation (ODD).

About Zymedi

Zymedi is a global biopharmaceutical company committed to transforming the therapeutic landscape by redefining the biological roles of aminoacyl-tRNA synthetases (ARSs) and leveraging them as therapeutic targets and agents for the discovery and development of innovative treatments for patients with serious and life-threatening conditions that lack effective therapies or standard-of-care options.

For more information, please visit www.zymedi.com/

Lunit Submits 510(k) Application for Image-Based Breast Cancer Risk Prediction Model

By
Advertorial Desk
-

Submission marks a key regulatory milestone toward bringing SEER-calibrated, imaging-based risk assessment to U.S. screening programs

SEOUL, South Korea, Dec. 8, 2025 /PRNewswire/ — Lunit (KRX:328130), a leading provider of AI for cancer diagnostics and precision oncology, today announced that it has submitted a 510(k) premarket notification to the U.S. Food and Drug Administration (FDA) for Lunit INSIGHT Risk, a mammography-based five-year breast cancer risk prediction model. Potential clearance is expected in 2026.

Lunit INSIGHT Risk estimates a woman’s five-year breast cancer risk directly from screening mammograms (either synthetic or digital mammography) without the need for patient questionnaires. The technology was originally developed at Washington University School of Medicine in St. Louis by Dr. Graham Colditz and Dr. Shu (Joy) Jiang, and later acquired by Lunit.
It is the first AI solution to generate SEER-calibrated five years absolute risk estimates for U.S. women. For example, a 5 percent risk indicates that 5 of 100 women with similar risk profiles are expected to develop breast cancer within the next five years.

The model’s performance has been validated in two peer-reviewed studies published in JAMA Network Open and JCO Clinical Cancer Informatics, showing discriminative performance with 5-year AUCs up to 0.80 across diverse screening populations in the U.S. and Canada. These studies also showed consistent performance regardless of age, race, or breast density, supporting its potential for equitable clinical adoption.

“Image-based risk assessment represents an important step toward making breast cancer prevention more precise and more accessible,” said Graham Colditz, MD, DrPH, Professor of Washington University School of Medicine in St. Louis. “Our research has shown that mammography-derived five-year absolute risk can be both highly discriminative and well calibrated to U.S. disease incidence rates, allowing clinicians to identify women who may benefit most from supplemental screening or preventive strategies. With Lunit advancing this technology toward regulatory review, we have an opportunity to bring evidence-based, personalized risk prediction closer to routine clinical practice.”

The model received FDA Breakthrough Device Designation last April and Lunit had been participating in the FDA Total Product Lifecycle Advisory Program (TAP), which enables more structured and frequent engagement with the agency during development and review. The program also supports discussions with non-FDA stakeholders to expedite market adoption, clinical use, and patient access.

“Submitting our first 510(k) for an image-based risk prediction model is an important milestone for Lunit and for the advancement of personalized breast cancer screening,” said Brandon Suh, CEO of Lunit. “By delivering absolute, guideline-aligned five-year risk estimates directly from routine screening images, Lunit INSIGHT Risk aims to support earlier and more informed decisions in preventive care. We believe this approach can help health systems implement practical risk-stratified strategies as screening recommendations continue to evolve. As screening programs increasingly shift from a one-size-fits-all approach to more personalized, risk-informed pathways, we see this submission not only as a scientific milestone but also as a strategic step that positions Lunit to meet the changing needs of health systems and patients.”

Lunit INSIGHT Risk is designed to integrate with the company’s broader breast health portfolio, including Lunit INSIGHT MMG and DBT detection models and Volpara Risk Pathways, creating a comprehensive foundation for risk-informed care workflows that span assessment, imaging, reporting, and longitudinal follow-up.

About Lunit

Founded in 2013, Lunit (KRX: 328130) is a global leader on a mission to conquer cancer through AI. Our clinically validated solutions span medical imaging, breast health, and biomarker analysis—empowering earlier detection, smarter treatment decisions, and more precise outcomes across the cancer care continuum.

Lunit offers a comprehensive suite spanning risk prediction and early detection to precision oncology. Our FDA-cleared Lunit INSIGHT suite and breast health solutions support cancer screening in thousands of medical institutions worldwide, while the Lunit SCOPE platform is used in research partnership with global pharma and laboratory leaders for biomarker research, and companion diagnostic development.

Trusted by over 10,000 sites in more than 65 countries, Lunit combines deep medical expertise with continuously evolving datasets to deliver measurable impact—for patients, clinicians, and researchers alike. Headquartered in Seoul with global offices, Lunit is driving the worldwide fight against cancer. Learn more at lunit.io/en.

DXC Appoints Russell Jukes as Chief Digital Information Officer to Strengthen Unified Digital Strategy

By
Advertorial Desk
-

ASHBURN, Va., Dec. 8, 2025 /PRNewswire/ — DXC Technology (NYSE: DXC), a leading enterprise technology and innovation partner, today announced the appointment of Russell Jukes as Chief Digital Information Officer (CDIO). In this expanded role, Russell becomes the first to lead DXC’s end-to-end digital and AI agenda, accelerating the company’s AI-powered transformation and ensuring its global technology environment is optimized to support customers’ strategic operations and our employees AI fluency. 

DXC Appoints Russell Jukes as Chief Digital Information Officer to Strengthen Unified Digital Strategy
DXC Appoints Russell Jukes as Chief Digital Information Officer to Strengthen Unified Digital Strategy

Since joining DXC in 2017, Russell has played a pivotal role in shaping DXC’s digital strategy and global technology capabilities. He has overseen DXC’s enterprise technology environment and has been central to advancing modernization across platforms, applications, and employee experience. Most recently, he played a key role in supporting the development of Xponential, DXC’s proven AI framework that simplifies the complexity that often stalls large-scale AI adoption. 

As CDIO, Russell will bring together digital, information, and AI transformation agendas across the groups delivering services, solutions, and software to our customers. This approach reflects a broader industry shift in which digital leaders increasingly oversee AI investment and innovation, while technology leaders continue to run mission-critical environments. 

“Russell has been instrumental in leading DXC’s digital and technology transformation. He has modernized our core systems, empowered our teams with better tools, and strengthened our technology foundation to meet the needs of our customers. As DXC continues to expand our AI capabilities, his leadership will be essential in driving meaningful and measurable impact for our customers and for DXC.” Raul Fernandez, CEO, DXC 

The announcement further aligns DXC’s digital, data, and technology capabilities to accelerate enterprise-scale AI. In his expanded role, Russell will also advance DXC’s Human+ ways of working, introducing new models that enhance how teams collaborate, learn, and build next-generation solutions. 

“I am honored to take on this expanded role at a time when digital, information, and AI must operate as one connected strategy. This structure gives us the clarity and alignment needed to innovate faster, run smarter, and help our customers transform with confidence. I look forward to building on the momentum of Xponential and supporting the next wave of AI-driven capabilities across DXC.” Russell Jukes, Chief Digital Information Officer, DXC 

Before joining DXC, Russell held senior roles across global technology organizations at HP and HPE, where he led modernization, enterprise engineering, and digital operations programs. He also sponsors DXC talent and innovation initiatives focused on cloud transformation and responsible AI adoption. 

About DXC Technology
DXC Technology (NYSE: DXC) is a leading enterprise technology and innovation partner delivering software, services, and solutions to global enterprises and public sector organizations — helping them harness AI to drive outcomes at a time of exponential change with speed. With deep expertise in Managed Infrastructure Services, Application Modernization, and Industry-Specific Software Solutions, DXC modernizes, secures, and operates some of the world’s most complex technology estates. Learn more on dxc.com 

Abstract and Open World Partner to Launch the First National-Scale Tokenization Engine for the World’s Most Valuable Real-World Assets

By
Advertorial Desk
-

For the first time, the world’s most strategic assets—AI supercomputing centers, strategic real estate and critical energy assets—are crossing the threshold into programmable digital markets.

NEW YORK, Dec. 8, 2025 /PRNewswire/ — The global economy is entering a new era where competitive advantage is defined not by access to capital alone, but by control of computational power, sovereign data, and the infrastructure that fuels modern civilization. Today, Abstract and Open World announce a landmark partnership to build the world’s first national-scale real-world asset (RWA) tokenization engine, capable of bringing the planet’s most valuable physical assets onto a next-generation, quantum-resistant zero-knowledge (ZK) blockchain anchored to Ethereum.

For decades, the planet’s most valuable assets have existed beyond the reach of modern digital markets. Hyperscale AI megacenters humming with the densest clusters of NVIDIA’s most advanced GPUs. Oil fields that fuel nations strategic national infrastructure. Energy grids, industrial complexes, sovereign reserves—all immense in value, yet trapped inside analog capital structures accessible only to a narrow band of global institutions.

Now, for the first time, these assets are stepping into the digital world and accessible to mainstream global investors.

AI megacenters and national energy reserves can be represented as tokenized Blue Chip real-world assets—unlocking liquidity, enabling compliant fractional ownership, and giving governments, regulated central organizations, and enterprises unprecedented control over how capital forms, moves, and interacts with their most strategic physical infrastructure and assets.

The Infrastructure: An Enterprise-Grade, Quantum-Resistant ZK Blockchain

At the center of this transformation will be Abstract’s next-generation, quantum-resistant ZK blockchain, backed by leading technology investors, including Peter Thiel’s Founders Fund, demonstrating how advanced blockchain technologies will enable new forms of tokenization by sovereign nations and enterprises operating at global scale.

Unlike legacy blockchains that expose data, or permissioned chains controlled by small validator groups, Abstract aims to deliver the scale, privacy, and decentralization guarantees required for trillion-dollar capital systems:

  • Over 10,000 TPS throughput
  • Low cost per transaction ($0.001)
  • Zero-knowledge cryptography for user and data privacy
  • Embedded policy controls, and absolute sovereign and enterprise-grade command.

The very pillars required for secure, compliant, nation-grade digital asset infrastructure.

“Our partnership with Abstract aims to unlock a new category of Blue Chip RWAs,” said Matt Shaw, Co-founder and CEO of Open World. Open World has already tokenized over $65 billion in premium crypto assets to date, providing institutional-scale infrastructure for real-world asset deployment. “Our RWA tokenization engine on Abstract will be a quantum-resistant platform for national economies—built for countries and enterprises that manage critical infrastructure, sovereign monetary systems, and multi-trillion-dollar asset portfolios.“

Internet Capital Markets: Tokenizing the World’s Most Premium RWAs

Through this alliance, AI supercomputing facilities—cathedrals of silicon and energy—can be expressed as programmable Blue Chip digital assets. Oil fields and energy infrastructure, long considered too strategic or politically sensitive to open to global capital markets, can now be represented as value appreciating premium digital instruments within fully compliant, sovereign or corporate frameworks.

The implications are profound. Liquidity can flow into assets previously inaccessible. Nations and global enterprises can modernize capital formation without relinquishing control. Global investors can access assets that define the 21st century—not as speculative tokens, but as regulated, institutional-grade digital instruments.

“Abstract unlocks what we call Internet Capital Markets, a world where financial systems live natively on the internet and move at the speed of culture,” said Abstract Co-Founder and CEO Michael Lee. “It complements traditional markets with a permissionless, borderless, high-throughput quantum-resistant blockchain that makes capital formation and trading as accessible and instant as posting online.“

Leaders from both organizations emphasized that this partnership is not merely commercial, it marks the moment financial systems begin operating natively on the internet: borderless, programmable, always on. By converting institutional real-world and digital assets into instant, compliant, globally accessible instruments, capital can finally move with the speed of culture and computation.

Why National-Scale Tokenization Requires Abstract and Ethereum, Not Centralized Chains

Sovereign stablecoins and national-grade RWA systems require unprecedented guarantees of decentralization, collusion resistance, and censorship immunity—standards centralized chains structurally cannot meet.

Russ McMeekin, Chairman of mCloud Saudi Arabia the Google Cloud Certified Web3 Platform running in the KSA Sovereign Data Center and leader of the global enterprise RWA initiative, explained, “The tokenization of premium Blue Chip RWAs demands the highest levels of security, compliance, and architectural sovereignty. Abstract on Ethereum is the only stack capable of delivering national-scale, enterprise-grade security tokenization and stablecoin issuance, while giving enterprises complete control within their own data centers. No foreign entity can freeze transactions, impose blacklists, or seize assets.“

Permissioned blockchains rely on a few hundred coordinated validators, an unacceptable risk surface for national infrastructure. Many public chains have repeatedly halted and restarted, demonstrating that their validator sets can coordinate to rewrite state. For sovereign and enterprise assets, this risk is existential.

Ethereum, secured by over one million active validators, stands alone as the most decentralized, economically secure, and censorship-resistant settlement layer in history. Abstract inherits Ethereum’s security and settlement guarantees while adding:

  • Sovereign-grade privacy
  • National-scale throughput
  • Embedded compliance and policy controls
  • On-premise deployment within enterprise and government datacenters

This ensures that AI megacenters, energy assets, and national infrastructure can be digitized without sacrificing sovereignty or control.

About Abstract
Abstract is a quantum-resistant zero-knowledge blockchain anchored to Ethereum, built for the next cultural era of the internet—where a new generation demands fun, ownership, and creativity, and where sovereign nations and global enterprises are transitioning from legacy financial systems to privacy-preserving stablecoins. Backed by Founders Fund and created by builders behind Ethereum, Pudgy Penguins, and Kubernetes, Abstract powers high-scale consumer experiences across gaming, digital collectibles, and the creator economy, while enabling compliant stablecoin issuance and premium real-world asset tokenization for enterprises and nation-states. Abstract sits at the intersection of culture and computation, building the digital infrastructure where the next generation will live, create, and transact. Learn more at abs.xyz.

Media Contact
Sunshine Sachs Morgan & Lylis (on behalf of Abstract)
abstract@ssmandl.com

Navitas, Cyient Semiconductors enter into a strategic partnership to accelerate GaN adoption in India’s AI, Mobility, Industrial, and Energy Markets

By
Advertorial Desk
-

TORRANCE, Calif. and HYDERABAD, India, Dec. 8, 2025 /PRNewswire/ — Navitas Semiconductor Corporation (Nasdaq: NVTS), the industry leader in next-generation GaNFast™ gallium nitride (GaN) and GeneSiC™ silicon carbide (SiC) power semiconductors and Cyient Semiconductors Private Limited, a fast-growing provider of ASIC, ASSP and power solutions provider have announced a strategic long-term partnership intended to advance the adoption of GaN technology in India and establish a complete, end-to-end GaN ecosystem.  

Through this partnership, Navitas Semiconductor and Cyient Semiconductors intend to co-develop GaN products, digital and mixed signal ICs, GaN based system modules and design enablement platforms targeting India’s high voltage, high power market segments such as AI data centers, electric mobility, performance computing, energy grid infrastructure and industrial electrification.  

The partnership seeks to build a robust local supply chain and manufacturing ecosystem in support of the Indian Government’s “Make in India” initiative. In addition, through this partnership Navitas and Cyient Semiconductor aims to deploy IC technology in accelerating solution development for high voltage and high-power markets.

This is expected to include products based on Navitas’ existing GaN technologies, along with new products tailored for India’s unique market needs. Cyient Semiconductors’ work in establishing a secure local supply chain and ecosystem for GaN products in India will further accelerate time to market for developers and OEMs across the region. 

Suman Narayan, CEO, Cyient Semiconductors, said, “This partnership represents a pivotal step in India’s semiconductor future in solving the complexities of power delivery at high voltages. By combining Navitas’ proven GaN technology with Cyient Semi’s design, manufacturing, and supply-chain strengths, we’re creating a self-sustaining ecosystem that will accelerate the market adoption of GaN. Our goal is to make GaN accessible to every OEM looking to design, build, and scale from India.” 

“I believe the growth of GaN technology in India will exceed global trends, and Cyient Semiconductors is the perfect partner for Navitas to drive this revolution,” said Chris Allexandre, President and CEO of Navitas. “Together, Navitas and Cyient will power India’s vision of India for India – innovation, by India, for the world.” 

This initiative is intended to empower Indian design houses and OEMs with locally sourced GaN components and manufacturing support, enabling faster development cycles and reducing barriers to GaN adoption in India. It also reinforces Cyient Semiconductors’ ambition to driving semiconductor innovation, localization, and scalability across critical technology sectors. 

This collaboration between Cyient Semiconductors and Navitas establishes a direct channel for Indian customers to access GaN technology, along with reliable procurement, engineering collaboration and technical support. 

For more information on the partnership and products please visit https://navitassemi.com/ or cyinetsemi.com/GaN.

About Navitas
Navitas Semiconductor (Nasdaq: NVTS) is a next-generation power semiconductor leader in gallium nitride (GaN) and IC integrated devices, and high-voltage silicon carbide (SiC) technology, driving innovation across AI data centers, performance computing, energy and grid infrastructure, and industrial electrification. With more than 30 years of combined expertise in wide bandgap technologies, GaNFast™ power ICs integrate GaN power, drive, control, sensing, and protection, delivering faster power delivery, higher system density, and greater efficiency. GeneSiC™ high-voltage SiC devices leverage patented trench-assisted planar technology to provide industry-leading voltage capability, efficiency, and reliability for medium-voltage grid and infrastructure applications. Navitas has over 300 patents issued or pending and is the world’s first semiconductor company to be CarbonNeutral®-certified. 

Navitas Semiconductor, GaNFast, GaNSense, GaNSafe, GeneSiC, and the Navitas logo are trademarks or registered trademarks of Navitas Semiconductor Limited or affiliates. All other brands, product names and marks are or may be trademarks or registered trademarks used to identify products or services of their respective owners. 

About Cyient Semiconductors
Cyient Semiconductors is a Hyderabad-headquartered provider of custom ASIC/ASSP solutions, with a focus on analog mixed-signal, intelligent power, and advanced semiconductor platforms. With design centers in India, Belgium, and the U.S., Cyient Semiconductors enables global customers in data centers, robotics, automotive, and industrial automation to achieve higher efficiency and faster time-to-market. 

Cautionary Statement Regarding Forward-Looking Statements
This press release includes “forward-looking statements” within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements are attempts to predict or indicate future events or trends or similar statements that are not a reflection of historical fact. Forward-looking statements may be identified by the use of words such as “we expect” or “are expected to be,” “estimate,” “plan,” “project,” “forecast,” “intend,” “anticipate,” “believe,” “seek,” or other similar expressions. Forward-looking statements are made based on estimates and forecasts of financial and performance metrics, projections of market opportunity and market share and current indications of customer interest, all of which are based on various assumptions, whether or not identified in this press release. All such statements are based on current expectations of the management of Navitas and Cyient and are not predictions of actual future performance. Forward-looking statements are provided for illustrative purposes only and are not intended to serve as, and must not be relied on by any investor as, a guarantee, an assurance, a prediction or a definitive statement of fact or probability. Actual events and circumstances are difficult or impossible to predict and will differ from assumptions and expectations. Many actual events and circumstances that affect performance are beyond the control of Navitas and/or Cyient, and forward-looking statements are subject to a number of uncertainties. Our businesses are subject to certain risks that could materially and adversely affect our respective business, financial condition, results of operations, or the value of our securities. For Navitas, these and other risk factors are discussed in the Risk Factors section beginning on p. 15 of our annual report on Form 10-K for the year ended December 31, 2024, as updated in the Risk Factors section of our most recent quarterly report on Form 10-Q, and in other documents we file with the SEC. If any of these risks, as discussed in more detail in our SEC reports, materialize or if our assumptions underlying forward-looking statements prove to be incorrect, actual results could differ materially from the results implied by these forward-looking statements.

Navitas Contact Information
Vipin Bothra
info@navitassemi.com  

Navitas Investor Contacts
Leanne Sievers | Brett Perry
Shelton Group
sheltonir@sheltongroup.com

Cyient Semiconductors Contact
Phalguna Hari jandhyala
phalguna.harijandhyala@cyient.com  

1...1,5431,5441,545...6,439Page 1,544 of 6,439